Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Reyataz“
Suchtreffer
Begriffe & Kennungen
Reyataz · 4.3 · Patients with moderate to severe hepatic insufficiency (see sections 4.2 and 4.4).
Eintrag öffnenReyataz · 4.3 · REYATAZ is contraindicated in patients with severe hepatic insufficiency (see sections 4.2, 4.4 and 5.2). REYA
Eintrag öffnenReyataz · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenReyataz · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenReyataz · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenReyataz · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenReyataz · 4.5 · **Based on historical comparison.
Eintrag öffnenReyataz · 4.5 · *Effect of atazanavir and ritonavir on the first dose of glecaprevir and pibrentasvir is reported. ANTIPLATELE
Eintrag öffnenReyataz · 4.5 · *In a combined analysis, atazanavir 300 mg and ritonavir 100 mg (n = 33) was compared to atazanavir 400 mg wit
Eintrag öffnenReyataz · 4.5 · *Lack of pharmacokinetics interaction bounds 70-143%
Eintrag öffnenReyataz · 4.5 · *Lack of pharmacokinetics interaction bounds 70-143%
Eintrag öffnenReyataz · 4.5 · *When compared to REYATAZ 300 mg and ritonavir 100 mg without nevirapine. This decrease in atazanavir Cmin mig
Eintrag öffnenReyataz · 4.5 · 10 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration ANTI-RETRO
Eintrag öffnenReyataz · 4.5 · 11 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration Didanosine
Eintrag öffnenReyataz · 4.5 · 12 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration Nevirapine
Eintrag öffnenReyataz · 4.5 · 13 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration Voriconazo
Eintrag öffnenReyataz · 4.5 · 14 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration ANTIMYCOBA
Eintrag öffnenReyataz · 4.5 · 14-OH clarithromycin 14-OH clarithromycin AUC: ↓70% (↓74% ↓66%) 14-OH clarithromycin Cmax: ↓72% (↓76% ↓67%) 14
Eintrag öffnenReyataz · 4.5 · 15 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration ACID REDUC
Eintrag öffnenReyataz · 4.5 · 16 Medicinal products by Interaction Recommendations concerning co- therapeutic area administration Proton pum
Eintrag öffnen